Hernia surgery drug trial halted early – what it means for patients

NCT ID NCT04491526

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether tamsulosin, a drug used for prostate symptoms, could prevent men from having trouble urinating after hernia repair. The trial planned to include 312 men aged 60 and older, but it was stopped early. Because it was terminated, we cannot draw firm conclusions about whether the drug works for this purpose.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

tamsulosin

What this could lead to

If effective, tamsulosin could reduce the need for catheterization after hernia surgery, making recovery easier for men.

What could go wrong

The trial was terminated early, so we don't have clear evidence. Tamsulosin may cause dizziness or low blood pressure in some men.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for URINARY RETENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hernia, Inguinal Urinary Retention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kantonsspital Baden

    Baden, Canton of Aargau, 5404, Switzerland